A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine pilot safety and efficacy data for a
topical formulation of EM-1421 applied to the cervix of patients with CIN 1, 2, or 3.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Erimos Pharmaceuticals
Collaborators:
Planned Parenthood Delaware (Wilmington, DE) University of Maryland, Baltimore County